IDEAYA Biosciences
Senior Director, Darovasertib Brand Lead
IDEAYA Biosciences, South San Francisco, California, us, 94083
Senior Director, Darovasertib Brand Lead
Join IDEAYA Biosciences as Senior Director, Darovasertib Brand Lead. This role leads brand strategy and launch execution for Darovasertib, a precision oncology therapy for uveal melanoma in the US.
About IDEAYA Biosciences IDEAYA is a precision medicine oncology company focused on discovering, developing, and commercializing transformative therapies. The company integrates small‑molecule drug discovery with robust biomarker validation to create first‑in‑class therapies for genetically defined solid tumors. Its mission is to provide highly selective, effective, and personalized treatments for cancer patients.
Location South San Francisco, CA. The position is onsite four days per week.
Position Summary Reporting to the VP of Marketing and Commercial Strategy, you will shape the strategic vision, drive cross‑functional launch readiness, and execute the integrated marketing plan. Your leadership will ensure successful market introduction and rapid sustained growth for Darovasertib.
What you’ll do
Lead the overall Darovasertib brand strategy and launch execution, including positioning, messaging, and go‑to‑market planning across HCP and patient segments.
Drive commercial readiness and ensure alignment across Medical Affairs, Market Access, Sales, Corporate Communications, and partner Servier for consistent life‑cycle planning.
Collaborate with digital and patient programs to maintain brand‑strategy alignment across all tactics.
Translate complex clinical and scientific data into differentiated brand narratives that resonate with stakeholders.
Oversee marketing campaigns, guiding omnichannel execution (digital, field, congress, peer‑to‑peer), content creation, and tactical planning.
Partner with Sales Leadership and Field Teams to translate brand strategy into actionable field tactics, tools, and messaging that drive execution excellence and customer engagement.
Develop and deliver field training materials and launch resources for consistent, confident customer‑facing teams.
Use field insights and analytics to identify market opportunities, feedback trends, and competitive intelligence for continuous brand refinement.
Serve as the strategic bridge between marketing and sales, ensuring real‑time communication, alignment, and shared accountability for launch and post‑launch success.
Manage budget, agencies, and vendors to ensure high‑quality, efficient execution and fiscal discipline.
Lead a small team at the outset with growth potential as the brand/lifecycle expands.
Continuously monitor brand performance and market dynamics, leveraging insights to optimize strategy and execution.
Lead, mentor, and empower cross‑functional teams, fostering a collaborative, high‑performing culture.
Represent the commercial voice in senior leadership discussions and contribute strategic input to pipeline and life‑cycle planning.
Travel: approximately 20%.
Requirements
Bachelor’s degree in Business, Marketing, or Life Sciences; MBA or advanced degree preferred.
10+ years of pharmaceutical/biotech commercial experience, with significant oncology brand leadership.
Proven success launching a first‑in‑class or specialty oncology product in the US.
Deep understanding of oncology market dynamics, HCP engagement, and patient‑centric marketing.
Strong ability to translate scientific data into clear strategic positioning and communication.
Experience leading cross‑functional launch teams, delivering in a matrix environment, and managing agency partnerships.
Excellent strategic thinking, communication, and leadership skills.
Experience in rare disease or ophthalmic oncology preferred.
Familiarity with digital marketing, omnichannel engagement, and data‑driven decision making.
Global or lifecycle management experience in a biotech environment.
Strategic leadership: anticipates market dynamics and creates bold, actionable strategies.
Cross‑functional influence: excels in matrix environments, aligning diverse teams around shared goals.
Patient‑centric mindset: prioritizes patient needs in all decisions.
Scientific acumen: conveys complex clinical data accessibly and differentiatedly.
Execution excellence: delivers results with urgency, quality, and agility.
Collaborative culture builder: inspires and empowers high‑performing teams.
Total Rewards The expected salary range is $273,000–$337,000, plus merit‑based increases, discretionary short‑term incentive participation, and stock‑option awards. Benefits include comprehensive medical, dental, vision coverage (100% company paid for employees, 90% for dependents), 401(k), ESPP, and wellness programs.
Equal Opportunity Statement IDEAYA complies with all applicable equal‑employment‑opportunity laws and does not discriminate based on race, color, religion, sex, national origin, age, marital or veteran status, disability, sexual orientation, or any other legally protected status. This position requires fully vaccinated employees (except as required by applicable law). The company considers individuals fully vaccinated once 14 days have passed since they received a COVID‑19 vaccine series. Vaccinations must be FDA‑approved or WHO–listed for emergency use.
#J-18808-Ljbffr
About IDEAYA Biosciences IDEAYA is a precision medicine oncology company focused on discovering, developing, and commercializing transformative therapies. The company integrates small‑molecule drug discovery with robust biomarker validation to create first‑in‑class therapies for genetically defined solid tumors. Its mission is to provide highly selective, effective, and personalized treatments for cancer patients.
Location South San Francisco, CA. The position is onsite four days per week.
Position Summary Reporting to the VP of Marketing and Commercial Strategy, you will shape the strategic vision, drive cross‑functional launch readiness, and execute the integrated marketing plan. Your leadership will ensure successful market introduction and rapid sustained growth for Darovasertib.
What you’ll do
Lead the overall Darovasertib brand strategy and launch execution, including positioning, messaging, and go‑to‑market planning across HCP and patient segments.
Drive commercial readiness and ensure alignment across Medical Affairs, Market Access, Sales, Corporate Communications, and partner Servier for consistent life‑cycle planning.
Collaborate with digital and patient programs to maintain brand‑strategy alignment across all tactics.
Translate complex clinical and scientific data into differentiated brand narratives that resonate with stakeholders.
Oversee marketing campaigns, guiding omnichannel execution (digital, field, congress, peer‑to‑peer), content creation, and tactical planning.
Partner with Sales Leadership and Field Teams to translate brand strategy into actionable field tactics, tools, and messaging that drive execution excellence and customer engagement.
Develop and deliver field training materials and launch resources for consistent, confident customer‑facing teams.
Use field insights and analytics to identify market opportunities, feedback trends, and competitive intelligence for continuous brand refinement.
Serve as the strategic bridge between marketing and sales, ensuring real‑time communication, alignment, and shared accountability for launch and post‑launch success.
Manage budget, agencies, and vendors to ensure high‑quality, efficient execution and fiscal discipline.
Lead a small team at the outset with growth potential as the brand/lifecycle expands.
Continuously monitor brand performance and market dynamics, leveraging insights to optimize strategy and execution.
Lead, mentor, and empower cross‑functional teams, fostering a collaborative, high‑performing culture.
Represent the commercial voice in senior leadership discussions and contribute strategic input to pipeline and life‑cycle planning.
Travel: approximately 20%.
Requirements
Bachelor’s degree in Business, Marketing, or Life Sciences; MBA or advanced degree preferred.
10+ years of pharmaceutical/biotech commercial experience, with significant oncology brand leadership.
Proven success launching a first‑in‑class or specialty oncology product in the US.
Deep understanding of oncology market dynamics, HCP engagement, and patient‑centric marketing.
Strong ability to translate scientific data into clear strategic positioning and communication.
Experience leading cross‑functional launch teams, delivering in a matrix environment, and managing agency partnerships.
Excellent strategic thinking, communication, and leadership skills.
Experience in rare disease or ophthalmic oncology preferred.
Familiarity with digital marketing, omnichannel engagement, and data‑driven decision making.
Global or lifecycle management experience in a biotech environment.
Strategic leadership: anticipates market dynamics and creates bold, actionable strategies.
Cross‑functional influence: excels in matrix environments, aligning diverse teams around shared goals.
Patient‑centric mindset: prioritizes patient needs in all decisions.
Scientific acumen: conveys complex clinical data accessibly and differentiatedly.
Execution excellence: delivers results with urgency, quality, and agility.
Collaborative culture builder: inspires and empowers high‑performing teams.
Total Rewards The expected salary range is $273,000–$337,000, plus merit‑based increases, discretionary short‑term incentive participation, and stock‑option awards. Benefits include comprehensive medical, dental, vision coverage (100% company paid for employees, 90% for dependents), 401(k), ESPP, and wellness programs.
Equal Opportunity Statement IDEAYA complies with all applicable equal‑employment‑opportunity laws and does not discriminate based on race, color, religion, sex, national origin, age, marital or veteran status, disability, sexual orientation, or any other legally protected status. This position requires fully vaccinated employees (except as required by applicable law). The company considers individuals fully vaccinated once 14 days have passed since they received a COVID‑19 vaccine series. Vaccinations must be FDA‑approved or WHO–listed for emergency use.
#J-18808-Ljbffr